A natural product-like JAK2/STAT3 inhibitor induces apoptosis of malignant melanoma cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A natural product-like JAK2/STAT3 inhibitor induces apoptosis of malignant melanoma cells
Authors
Keywords
Apoptosis, Melanoma cells, Melanomas, Phosphorylation, Flow cytometry, MTT assay, STAT signaling, Signal inhibition
Journal
PLoS One
Volume 12, Issue 6, Pages e0177123
Publisher
Public Library of Science (PLoS)
Online
2017-06-02
DOI
10.1371/journal.pone.0177123
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Discovery of a VHL and HIF1α interaction inhibitor with in vivo angiogenic activity via structure-based virtual screening
- (2016) Chao Yang et al. CHEMICAL COMMUNICATIONS
- A Rhodium(III) Complex as an Inhibitor of Neural Precursor Cell Expressed, Developmentally Down-Regulated 8-Activating Enzyme with in Vivo Activity against Inflammatory Bowel Disease
- (2016) Hai-Jing Zhong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective and Potent Proteomimetic Inhibitors of Intracellular Protein-Protein Interactions
- (2015) Anna Barnard et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- Elucidation of Acquired Resistance to Bcl-2 and MDM2 Inhibitors in Acute Leukemia In Vitro and In Vivo
- (2015) C. G. Hoffman-Luca et al. CLINICAL CANCER RESEARCH
- In silico identification of natural product inhibitors of JAK2
- (2015) Hai-Jing Zhong et al. METHODS
- Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2
- (2015) De-Shen Wang et al. Oncotarget
- Small-Molecule Proteomimetic Inhibitors of the HIF-1α-p300 Protein-Protein Interaction
- (2014) George M. Burslem et al. CHEMBIOCHEM
- Virtual screening and optimization of Type II inhibitors of JAK2 from a natural product library
- (2014) Dik-Lung Ma et al. CHEMICAL COMMUNICATIONS
- Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
- (2014) Nagaraju Anreddy et al. MOLECULES
- OPB-31121, a novel small molecular inhibitor, disrupts the JAK2/STAT3 pathway and exhibits an antitumor activity in gastric cancer cells
- (2013) Mi-Jung Kim et al. CANCER LETTERS
- Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
- (2013) D. M. Molina et al. SCIENCE
- Antitumor agents 294. Novel E-ring-modified camptothecin–4β-anilino-4′-O-demethyl-epipodophyllotoxin conjugates as DNA topoisomerase I inhibitors and cytotoxic agents
- (2012) Deyong Ye et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Traditional Chinese medicine research in the post-genomic era: Good practice, priorities, challenges and opportunities
- (2012) Halil Uzuner et al. JOURNAL OF ETHNOPHARMACOLOGY
- The Novel BCR-ABL and FLT3 Inhibitor Ponatinib Is a Potent Inhibitor of the MDR-Associated ATP-Binding Cassette Transporter ABCG2
- (2012) R. Sen et al. MOLECULAR CANCER THERAPEUTICS
- Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells
- (2012) Sangkil Nam et al. Molecular Oncology
- BBA, a Derivative of 23-Hydroxybetulinic Acid, Potently Reverses ABCB1-Mediated Drug Resistance in Vitro and in Vivo
- (2012) Dong-Mei Zhang et al. MOLECULAR PHARMACEUTICS
- Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer
- (2012) G Sutendra et al. ONCOGENE
- Cytogenetic analyses of Azadirachtin reveal absence of genotoxicity but marked antiproliferative effects in human lymphocytes and CHO cells in vitro
- (2012) Pasquale Mosesso et al. TOXICOLOGY LETTERS
- Analysis of Flexibility and Hotspots in Bcl-xL and Mcl-1 Proteins for the Design of Selective Small-Molecule Inhibitors
- (2012) Chao-Yie Yang et al. ACS Medicinal Chemistry Letters
- Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent
- (2012) Rita Andraos et al. Cancer Discovery
- Smac-mimetic compound SM-164 induces radiosensitization in breast cancer cells through activation of caspases and induction of apoptosis
- (2011) Dong Yang et al. BREAST CANCER RESEARCH AND TREATMENT
- Cucurbitacin IIa: a novel class of anti-cancer drug inducing non-reversible actin aggregation and inhibiting survivin independent of JAK2/STAT3 phosphorylation
- (2011) C Boykin et al. BRITISH JOURNAL OF CANCER
- Curcumin Induces the Differentiation of Myeloid-Derived Suppressor Cells and Inhibits Their Interaction with Cancer Cells and Related Tumor Growth
- (2011) S. P. Tu et al. Cancer Prevention Research
- Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells
- (2010) Ioana Abraham et al. BIOCHEMICAL PHARMACOLOGY
- Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells
- (2010) Feng Li et al. CANCER LETTERS
- Cucurbitacin E, a tetracyclic triterpenes compound from Chinese medicine, inhibits tumor angiogenesis through VEGFR2-mediated Jak2-STAT3 signaling pathway
- (2010) Y. Dong et al. CARCINOGENESIS
- NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and mdulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts
- (2010) Karuppaiyah Selvendiran et al. CELL CYCLE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure-Based Design of Conformationally Constrained, Cell-Permeable STAT3 Inhibitors
- (2010) Jianyong Chen et al. ACS Medicinal Chemistry Letters
- Design, synthesis, and evaluation of peptidomimetics containing Freidinger lactams as STAT3 inhibitors
- (2009) Cindy Gomez et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Triptolide inhibits Jak2 transcription and induces apoptosis in human myeloproliferative disorder cells bearing Jak2V617F through caspase-3-mediated cleavage of Mcl-1
- (2009) Qi Chen et al. CANCER LETTERS
- Multimodal Assessment of Protein Functional Deficiency Supports Pathogenicity of BRCA1 p.V1688del
- (2009) A. De Nicolo et al. CANCER RESEARCH
- LYR71, a derivative of trimeric resveratrol, inhibits tumorigenesis by blocking STAT3-mediated matrix metalloproteinase 9 expression
- (2009) Ja Eun Kim et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Current systemic therapy for metastatic melanoma
- (2009) Sanjiv S Agarwala Expert Review of Anticancer Therapy
- The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-β signaling
- (2009) L Lin et al. ONCOGENE
- Current management of metastatic melanoma
- (2008) V. A. Trinh AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Guggulsterone, a Farnesoid X Receptor Antagonist, Inhibits Constitutive and Inducible STAT3 Activation through Induction of a Protein Tyrosine Phosphatase SHP-1
- (2008) K. S. Ahn et al. CANCER RESEARCH
- A Novel Inhibitor of Signal Transducers And Activators Of Transcription 3 Activation Is Efficacious Against Established Central Nervous System Melanoma and Inhibits Regulatory T Cells
- (2008) L.-Y. Kong et al. CLINICAL CANCER RESEARCH
- JAKs in pathology: Role of Janus kinases in hematopoietic malignancies and immunodeficiencies
- (2008) William Vainchenker et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now